Michael Petusky Upgraded (XRAY) to Buy on, Nov 6th, 2017
Michael has made no other calls on XRAY in the last 4 months.
There are 2 other peers that have a rating on XRAY. Out of the 2 peers that are also analyzing XRAY, 0 agree with Michael's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Michael
- Steve Beuchaw of "Morgan Stanley" Maintained at Buy with Increased Target to $69 on, Friday, October 6th, 2017
- Raghuram Selvaraju of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $74 on, Tuesday, July 11th, 2017
on: Thu, Aug 10th 2017
by: WOPRAI
Steve Beuchaw Maintained (XRAY) at Buy with Increased Target to $67 on, Aug 10th, 2017
on: Mon, Oct 30th 2017
by: WOPRAI
Mark May Maintained (AMZN) at Strong Buy with Increased Target to $63 on, Oct 30th, 2017
on: Tue, Nov 22nd 2016
by: WOPRAI
Michael Derchin Downgraded (UAL) to Hold and Increased Target to $76 on, Nov 22nd, 2016
on: Wed, Nov 01st 2017
by: WOPRAI
on: Wed, Oct 25th 2017
by: WOPRAI
Steven Pelayo Initiated (AAPL) at Strong Buy and Held Target at $48 on, Oct 25th, 2017
on: Mon, Oct 16th 2017
by: WOPRAI
on: Thu, Jan 05th 2017
by: WOPRAI
on: Fri, Nov 18th 2016
by: WOPRAI
Kevin Crissey Initiated (AAL) at Strong Buy and Held Target at $55 on, Nov 18th, 2016
on: Tue, Nov 19th 2013
by: WOPRAI
Michael Derchin Maintained (ALK) at Buy with Increased Target to $43 on, Nov 19th, 2013
on: Mon, Nov 18th 2013
by: WOPRAI
Andrew Didora Maintained (ALK) at Strong Buy with Increased Target to $42 on, Nov 18th, 2013
on: Fri, Oct 19th 2012
by: WOPRAI
Kenneth Worthington Upgraded (TROW) to Buy and Increased Target to $77 on, Oct 19th, 2012
on: Mon, Oct 08th 2012
by: WOPRAI